However, when treated HCC2279 cells combination of erlotinib and ABT-737 remarkably enhanced BIM expression and cleaved caspase-3 (Figure 6E), thereby re-sensitizing NSCLC cells expressing EGFR-mutant and harboring the BIM deletion polymorphism to apoptosis. Here, CASP3 is linked to non-small cell lung carcinoma.